Capricor Therapeutics
Duplicate source posts collapse into one event. Only direct subject-company stories are included in this public hub.
Piper Sandler upgraded AKAM, TEM, CAPR; Morgan Stanley upgraded HOOD; BofA downgraded PCG and EIX. Other changes include upgrades for TKO, DUOL, TDW, PK, NCDL, HTGC, TKR, COLB, SRE and downgrades for MYGN, MIAX, XHR. Price targets adjusted.
analyst action · Impact 30Raymond James upgraded AMD to Strong Buy with a $641 price target. Morgan Stanley raised DT to Overweight. Jefferies downgraded RLI to Underperform. Goldman Sachs cut DQ to Sell. Multiple other rating changes hit mid-caps.
Explore the exact intelligence modules available on every supported company page.
